Sort
64,565 grants matching “drug discovery”
Hematalogical Malignancies
$693,252Richard James Gilbertson · St. Jude Children'S Research Hospital · P30 · FY2016 · CA
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
$693,240Josh F. Peterson · Vanderbilt University Medical Center · U01 · FY2024 · HG
Signal Transduction Events and the Regulation of Cell Growth
$693,164Jane B Trepel · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA
Epigenetic Marks of Cocaine Addiction
$693,158Deborah C. Mash · University Of Miami School Of Medicine · R01 · FY2013 · DA
A High-Throughput Cell-based Drug Discovery System
$693,120Rajan Kumar · Genome Data Systems, Inc. · R44 · FY2006 · DK
Expertise in Professional Pharmaceutical Project Management
$693,109Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2024 · AI
Identifying the genetic causes of depression in a deeply phenotyped population from South Korea
$693,090Jonathan Flint · University Of California Los Angeles · U01 · FY2025 · MH
Project 2: Response to Treatment
$693,087David R Sherman · Seattle Children'S Hospital · U19 · FY2020 · AI
Molecular Target Focused Discovery of Anticancer Drugs
$693,085Arizona State University-Tempe Campus · R01 · FY2001 · CA
UniProt Partnerships with Common Fund Data Ecosystem Resources for Protein-Centric Functional Genomics
$693,012Cathy H Wu · University Of Delaware · U24 · FY2024 · OD
Core G: Religious Orders Study Core
$692,946David A Bennett · Rush University Medical Center · P30 · FY2016 · AG
Core G: Religious Orders Study Core
$692,946David A Bennett · Rush University Medical Center · P30 · FY2017 · AG
Core G: Religious Orders Study Core
$692,945David A Bennett · Rush University Medical Center · P30 · FY2018 · AG
Engineered probiotic for the treatment of autoimmune diseases
$692,859Christine Beeton · Baylor College Of Medicine · R01 · FY2025 · AI
RADIOTRACER R &D IN NUCLEAR MEDICINE AND NEUROSCIENCES
$692,852Brookhaven Science Assoc-Brookhaven Lab · R01 · FY2003 · EB
Kv7.2/7.3 Activators for the Treatment of Epilepsy Disorders
$692,846Michael Bozik · Knopp Biosciences, Llc · U44 · FY2018 · NS
Centralized assay datasets for modelling support of small drug discovery organizations
$692,845Sean Ekins · Collaborations Pharmaceuticals, Inc. · R44 · FY2019 · GM
Clinical translation of a NexGen platform for quantifying protein networks in human biospecimens
$692,845Amanda G Paulovich · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Structural, mechanistic, & evolutionary characterization of tetracycline destructases
$692,841Gautam Dantas · Washington University · U01 · FY2023 · AI
Development and Prevention of Substance Abuse Problems
$692,824Kenneth A Dodge · Duke University · R01 · FY2012 · DA
Analysis of protein interactions in neurodegenerative disease
$692,796John Robert Yates · Scripps Research Institute, The · R01 · FY2025 · AG
Orexin Receptor Antagonism for the Treatment of Alcohol Use Disorder and Stress-Related Drinking
$692,723Stephanie Gorka · Ohio State University · R01 · FY2025 · AA
Contributions of aberrant synaptic protein monoaminylation to opiate use disorder
$692,516Ian S. Maze · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DA
Phenotype MicroArrays for Drug Toxicity Screening
$692,454Barry Ronald Bochner · Biolog, Inc. · R44 · FY2006 · MH
Integrating Chemistry and Evolution to Illuminate Biology and Enable Novel Therapeutics
$692,434David R Liu · Broad Institute, Inc. · R35 · FY2019 · GM